Polatuzumab Vedotin联合苯达莫司汀及利妥昔单抗(pola-BR)对比苯达莫司汀联合利妥昔单抗(BR)治疗复发/难治性DLBCL的疗效分析
The Journal of Evidence-Based Medicine（2020）
Abstract
1 文献来源
Sehn LH, Herrera AF, Flowers CR,et al. Polatuzumab Vedotin in relapsed or refractory diffuse large B-cell lymphoma[J]. J Clin Oncol,2020,38 (2):155-165.
MoreAI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined